Company intelligence / Profile preview
PeptiDream Inc.
Kawasaki City, Kanagawa Prefecture, Japanpeptidream.com ↗
- Ownership
- Private
- Employees
- ~732
- Development stage
- Phase 3
01
Overview
PeptiDream has multiple programs in clinical development, with lead candidates in Phase 3 trials including 64Cu-ATSM for malignant brain tumors and 177Lu/64Cu-PSMA I&T for prostate cancer. The company has a robust pipeline spanning preclinical to Phase 3 stages.
- Therapeutic areas
- OncologyImmunologyNeurology
- Modalities
- Macrocyclic peptidesPeptide therapeuticsSmall moleculesPeptide-drug conjugates (PDCs)Multi-functional peptide conjugates (MPCs)Radiopharmaceuticals
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
Beyond the preview
Go deeper on PeptiDream Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PeptiDream Inc..